Healthcare · Diagnostics & Research
Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Medical Devices & Tools · Mean-Reversion | DOWN 100% | Mean-Reversion — contrarian on the trailing return. DHR ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile, recent move +6.2%, fading it), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Bollinger Reversion | DOWN 89% | Bollinger Reversion — fade moves outside the bands. DHR ranks #5 of 10 in Medical Devices & Tools (89% bearish percentile), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 83% | Long-Term Reversal — year-long losers rebound. DHR ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile, signal -6.3%), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Mean-Reversion | DOWN 83% | Mean-Reversion — contrarian on the trailing return. DHR ranks #7 of 13 in Pharma & Managed Care (83% bearish percentile, recent move +6.2%, fading it), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · 52-Week-High | UP 78% | 52-Week-High — proximity to the trailing high. DHR ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, 89% of its 52-week high), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Low Volatility | DOWN 78% | Low Volatility — the low-volatility anomaly. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile, annualized volatility 40%), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · OBV Trend | DOWN 78% | OBV Trend — on-balance-volume accumulation. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Quality | DOWN 78% | Quality — operating margin plus revenue growth. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Regime Switch | DOWN 78% | Regime Switch — the market looks high_vol, so it ranked on Low Volatility. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · RSI Mean-Reversion | DOWN 78% | RSI Mean-Reversion — oversold up / overbought down. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile, RSI 71), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Vol-Adjusted Momentum | UP 78% | Vol-Adjusted Momentum — return per unit of recent volatility. DHR ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, return/volatility +0.07), so the agent calls it UP for the next session. |
| Pharma & Managed Care · MACD | UP 75% | MACD — MACD histogram momentum crossover. DHR ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · OBV Trend | DOWN 75% | OBV Trend — on-balance-volume accumulation. DHR ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile), so the agent calls it DOWN for the next session. |
Best agents on DHR (graded record)
| Mean-Reversion Agent | 100% | 2/2 correct | UP |
| Medical Devices & Tools · Dual Momentum | 100% | 1/1 correct | UP |
| Pharma & Managed Care · MACD | 69% | 9/13 correct | UP |
| Medical Devices & Tools · 52-Week-High | 68% | 13/19 correct | UP |
| Medical Devices & Tools · Low Volatility | 65% | 11/17 correct | DOWN |
| Medical Devices & Tools · Breakout | 64% | 14/22 correct | UP |
| Medical Devices & Tools · Donchian | 64% | 14/22 correct | UP |
| Pharma & Managed Care · Momentum | 63% | 12/19 correct | UP |
| Medical Devices & Tools · Meta-Ensemble | 61% | 11/18 correct | UP |
| Pharma & Managed Care · Long-Term Reversal | 61% | 25/41 correct | UP |
Recent news
| 2026-08-24 | Is Danaher’s (DHR) Acquisition-Driven Strategy Masking Deeper Questions About Organic Growth And Margins? - simplywall.st · simplywall.st |
| 2026-08-24 | Is Danaher’s (DHR) Acquisition-Driven Strategy Masking Deeper Questions About Organic Growth And Margins? - simplywall.st · simplywall.st |
| 2026-08-24 | Qiagen names Jonathan Pratt as CEO amid takeover talks · yf_tkr_DHR |
| 2026-08-24 | 1 Profitable Stock with Exciting Potential and 2 We Brush Off · yf_tkr_DHR |
| 2026-08-20 | Danaher (DHR) Jumped, But What Is Drawing Fresh Attention Now? · yf_tkr_DHR |
| 2026-08-20 | Danaher (DHR) Stock Looks Fairly Valued On Its 23% Five Year Slide · yf_tkr_DHR |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。